PPARD and metabolic disease: PPARβ/δ could be targeted by a specific agonist in skeletalmuscle in order to prevent metabolic disorders such as insulin resistance andobesity by increasing catabolism of lipid in muscle and decreasing lipidaccumulation in adipose tissue.